Ken Griffin (Citadel Advisors) exit Gilead Sciences, Inc.
Ken Griffin (Citadel Advisors) exit $-743.5M of disclosed value in Gilead Sciences, Inc..
Signal
Investor Move
Action
Exit
Capital
$-743.5M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.